Evidence map›Paper›PMID 31658764›Full record

ArticleInternational journal of molecular sciences2019

B-Cell Activating Factor Enhances Hepatocyte-Driven Angiogenesis via B-Cell CLL/Lymphoma 10/Nuclear Factor-KappaB Signaling during Liver Regeneration.

Chia-Hung Chou, Cheng-Maw Ho, Shou-Lun Lai, Chiung-Nien Chen, Yao-Ming Wu, Chia-Tung Shun, Wen-Fen Wen, Hong-Shiee Lai

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. [Expression of MMP-9 and microvessels in rat organs with chronic mountain sickness].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2021
    Article
  8. Noncanonical NF-κB Signaling Pathway in Liver Diseases.Journal of clinical and translational hepatology · 2021
    Review
  9. Wound Repair and Regeneration: Mechanisms, Signaling.International journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chia-Hung ChouDepartment of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 10002, Taiwan. ch640124@gmail.com.
Cheng-Maw HoDepartment of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 10002, Taiwan. miningho@ntu.edu.tw.ORCID 0000-0003-1874-7615
Shou-Lun LaiDepartment of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 10002, Taiwan. Sauron_lai@hotmail.com.
Chiung-Nien ChenDepartment of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 10002, Taiwan. cnchen@ntu.edu.tw.
Yao-Ming WuDepartment of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 10002, Taiwan. wyaoming@gmail.com.
Chia-Tung ShunDepartments of Forensic Medicine and Pathology, College of Medicine, National Taiwan University, Taipei 10617, Taiwan. ctshun@ntu.edu.tw.
Wen-Fen WenDepartments of Pathology, College of Medicine, National Taiwan University, Taipei 10617, Taiwan. wenwenfen@gmail.com.
Hong-Shiee LaiDepartment of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 10002, Taiwan. hslai@ntu.edu.tw.
National Taiwan University Hospital · TWNational Taiwan University · TWTzu Chi Foundation · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B-cell activating factor (BAFF) is found to be associated with the histological severity of nonalcoholic steatohepatitis (NASH). BAFF was also found to have a protective role in hepatic steatosis via down regulating the expression of steatogenesis genes and enhancing steatosis in hepatocytes through BAFF-R. However, the roles of BAFF during liver regeneration are not well defined. In this study, C57/B6 mice with 70% partial hepatectomy were used as a liver regeneration model. BAFF expression was determined by enzyme immunoassay, and anti-BAFF-neutralizing antibodies were administered to confirm the effects of BAFF on liver regeneration. Western blotting, immunohistochemistry, and florescence staining determined the expression of B-cell CCL/lymphoma 10 (BCL10). The angiogenesis promoting capability was evaluated after the transfection of cells with siRNA targeting BCL10 expression, and the role of NF-κB was assessed. The results revealed that the BAFF and BCL10 levels were upregulated after partial hepatectomy. Treatment with anti-BAFF-neutralizing antibodies caused death in mice that were subjected to 70% partial hepatectomy within 72 h. In vitro, recombinant BAFF protein did not enhance hepatocyte proliferation; however, transfection with BCL10 siRNA arrested hepatocytes at the G2/M phase. Interestingly, conditioned medium from BAFF-treated hepatocytes enhanced angiogenesis and endothelial cell proliferation. Moreover, Matrix metalloproteinase-9 (MMP-9), Fibroblast growth factor 4 (FGF4), and Interleukin-8 (IL-8) proteins were upregulated by BAFF through BCL10/NF-κB signaling. In mice that were treated with anti-BAFF-neutralizing antibodies, the microvessel density (MVD) of the remaining liver tissues and liver regeneration were both reduced. Taken together, our study demonstrated that an increased expression of BAFF and activation of BCL10/NF-κB signaling were involved in hepatocyte-driven angiogenesis and survival during liver regeneration.

Indexed as

Angiogenesis Inducing AgentsAnimalsAntibodies, NeutralizingB-Cell Activating FactorB-Cell CLL-Lymphoma 10 ProteinCell ProliferationEndothelial CellsFibroblast Growth Factor 4HepatectomyHepatocytesInterleukin-8LiverLiver RegenerationMaleMatrix Metalloproteinase 9MiceAngiogenesis Inducing AgentsAntibodies, NeutralizingB-Cell Activating FactorB-Cell CLL-Lymphoma 10 ProteinBcl10 protein, mouseFgf4 protein, mouseFibroblast Growth Factor 4Interleukin-8Matrix Metalloproteinase 9NF-kappa B70% partial hepatectomyangiogenesisB-cell activating factor (BAFF)B-cell CLL/lymphoma 10 (BCL10)liver regeneration

Identifiers

PMID31658764
PMCPMC6829427
OpenAlexW2979435206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.